Fortimedix has been acquired by Medtronic

Fortimedix Surgical has been successfully acquired by Medtronic (NYSE: MDT). Following the transaction, Fortimedix will operate as Medtronic Articulating Technologies.

Located at the Brightlands Chemelot Campus in Geleen, the Netherlands, Fortimedix operates a fully equipped R&D and pilot manufacturing facility that allows the seamless integration of product development and pilot manufacturing under a single roof.

Oaklins’ team in the Netherlands acted as the exclusive sell-side M&A advisor to Fortimedix in its sale to Medtronic. This transaction underscores Oaklins’ strong international track record in the medical technology sector, demonstrating their ability to unlock significant value in a rapidly evolving, innovation-driven industry. Leveraging deep sector expertise and a global network of strategic buyers, the team ensured a smooth and successful transaction process for all parties involved.

DIENSTLEISTUNG

Verkauf

PARTEIEN

«Our goal was to find a strategic partner for Fortimedix capable of bringing our innovative technologies into full-scale production and into operating rooms worldwide. With Medtronic, we have now found the right partner who can take the next step in delivering groundbreaking instruments to the clinic. The intensive and very pleasant collaboration with Oaklins ultimately led to this transaction. The team’s guidance and results-oriented approach proved invaluable throughout the entire process.»

Wout Bijker

CEO, Fortimedix Surgical

Sprechen Sie mit dem Deal Team

Robert Boersma

Partner

Amsterdam, Niederlande
Oaklins Netherlands

Kurzprofil Kontakt aufnehmen

Robbert Bon

Senior Associate

Amsterdam, Niederlande
Oaklins Netherlands

Kurzprofil Kontakt aufnehmen

Oscar van Rijn

Associate

Amsterdam, Niederlande
Oaklins Netherlands

Kurzprofil Kontakt aufnehmen

Transaktionen

Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland

Gesundheitswesen

Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland

Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.

Mehr erfahren

EuroHospital Varna has been acquired by Intermedica Group

Gesundheitswesen

EuroHospital Varna has been acquired by Intermedica Group

EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.

Mehr erfahren

Olyos Group has acquired a controlling stake in NewScience

Gesundheitswesen

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Mehr erfahren